BAFFX
Price
$44.42
Change
+$0.16 (+0.36%)
Updated
Sep 8 closing price
Net Assets
1.04B
GAFFX
Price
$86.88
Change
+$0.68 (+0.79%)
Updated
Sep 8 closing price
Net Assets
332.38B
Interact to see
Advertisement

BAFFX vs GAFFX

Header iconBAFFX vs GAFFX Comparison
Open Charts BAFFX vs GAFFXBanner chart's image
Brown Advisory Flexible Equity Inst
Price$44.42
Change+$0.16 (+0.36%)
VolumeN/A
Net Assets1.04B
American Funds Growth Fund of Amer F3
Price$86.88
Change+$0.68 (+0.79%)
VolumeN/A
Net Assets332.38B
BAFFX vs GAFFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BAFFX vs. GAFFX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAFFX is a Buy and GAFFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 332B vs. BAFFX (1.04B). GAFFX pays higher dividends than BAFFX: GAFFX (0.59) vs BAFFX (0.36). BAFFX was incepted earlier than GAFFX: BAFFX (13 years) vs GAFFX (9 years). BAFFX (0.53) is less costly to investors than GAFFX (0.30). GAFFX is a more actively managed with annual turnover of: 25.00 vs. BAFFX (15.00). BAFFX (1000000) and GAFFX (1000000) have matching initial minimum investment requirements. GAFFX annual gain was more profitable for investors over the last year : 22.13 vs. BAFFX (11.79). BAFFX return over 5 years is better than : 65.06 vs. GAFFX (46.66).
BAFFXGAFFXBAFFX / GAFFX
Total Expense Ratio0.530.30177%
Annual Report Gross Expense Ratio0.530.30177%
Fund Existence13 years9 years-
Gain YTD7.92016.66448%
Front LoadN/AN/A-
Min. Initial Investment10000001000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.04B332B0%
Annual Yield % from dividends0.360.5960%
Returns for 1 year11.7922.1353%
Returns for 3 years53.1554.2898%
Returns for 5 years65.0646.66139%
Returns for 10 years198.67N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DMAC7.161.02
+16.61%
DiaMedica Therapeutics
CTSO0.980.02
+1.74%
Cytosorbents Corp
HALO75.850.92
+1.23%
Halozyme Therapeutics
CHARU10.82N/A
N/A
Charlton Aria Acquisition Corp
TXG13.93-0.03
-0.21%
10x Genomics